Search - tctmd.com

Displaying 341 - 360 of 363

Sort: Relevancy | Date

News Industry News

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

May 16, 2012

News Industry News

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

April 27, 2012

Presentation GI2 2012

Rationale and Background to Treat Resistant Hypertension with Renal Denervation

Presenter: Martin B. Leon

April 13, 2012

News Industry News

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

April 09, 2012

News Conference News ACC 2012

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Yael L. Maxwell

March 27, 2012

Presentation ACC 2012

Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial

Presenter: Murray Esler

March 25, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Renal Denervation Bonus: Improving LV Function

March 05, 2012

News Daily News

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

March 05, 2012

Presentation

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

Presenter: M. Brandt

February 26, 2012

News Industry News

ReCor Medical announces CE mark approval for its novel PARADISE™ ultrasound transcatheter renal denervation system

February 19, 2012

Presentation ISET 2012

Will Renal Denervation and Other Interventions Be the Next Great Opportunity in Endovascular Therapy?

Presenter: Horst Sievert

January 15, 2012

Presentation TCT 2012

Catheter-Based Renal Sympathetic Denervation: Chronic Preclinical Evidence for Renal Artery Safety

Presenter: Marian K. Rippy, Denise M. Zarins, Neil C. Barman, Andrew E. Wu, Keith L. Duncan, Christopher K. Zarins

January 03, 2012

Presentation TCT 2012

Anatomic Substrate for Renal Sympathetic Denervation: A Human Post-Mortem Histological Study

Presenter: Farrell O. Mendelsohn, Nicholas L. Deep, Daniel S. Atherton

January 03, 2012

News Conference News

Renal Denervation Reduced BP in Majority of Patients

November 07, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Daily News

Endovascular Renal Nerve Ablation Safely Reduces BP During Exercise

Jason Kahn

August 29, 2011

News Industry News

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

July 11, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

Advertisement

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

Rationale and Background to Treat Resistant Hypertension with Renal Denervation

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial

Experts Give Their Picks for Most Important Developments of 2011

Renal Denervation Bonus: Improving LV Function

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

ReCor Medical announces CE mark approval for its novel PARADISE™ ultrasound transcatheter renal denervation system

Will Renal Denervation and Other Interventions Be the Next Great Opportunity in Endovascular Therapy?

Catheter-Based Renal Sympathetic Denervation: Chronic Preclinical Evidence for Renal Artery Safety

Anatomic Substrate for Renal Sympathetic Denervation: A Human Post-Mortem Histological Study

Renal Denervation Reduced BP in Majority of Patients

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Medtronic Starts Landmark Study of Hypertension Treatment

Endovascular Renal Nerve Ablation Safely Reduces BP During Exercise

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content